183 related articles for article (PubMed ID: 26070152)
1. Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer.
Putcha BD; Jia X; Katkoori VR; Salih C; Shanmugam C; Jadhav T; Bovell LC; Behring MP; Callens T; Messiaen L; Bae S; Grizzle WE; Singh KP; Manne U
PLoS One; 2015; 10(6):e0129216. PubMed ID: 26070152
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.
Katkoori VR; Jia X; Chatla C; Kumar S; Ponnazhagan S; Callens T; Messiaen L; Grizzle WE; Manne U
Front Biosci; 2008 Jan; 13():1050-61. PubMed ID: 17981610
[TBL] [Abstract][Full Text] [Related]
3. Cloning of a human ortholog (RPH3AL) of (RNO)Rph3al from a candidate 17p13.3 medulloblastoma tumor suppressor locus.
Smith JS; Tachibana I; Allen C; Chiappa SA; Lee HK; McIver B; Jenkins RB; Raffel C
Genomics; 1999 Jul; 59(1):97-101. PubMed ID: 10395805
[TBL] [Abstract][Full Text] [Related]
4. Mutations of rabphillin-3A-like gene in colorectal cancers.
Goi T; Takeuchi K; Katayama K; Hirose K; Yamaguchi A
Oncol Rep; 2002; 9(6):1189-92. PubMed ID: 12375017
[TBL] [Abstract][Full Text] [Related]
5. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A
Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
[TBL] [Abstract][Full Text] [Related]
9. [Molecular analysis of TP53, D9S1747, D9S162 and RPS6 in oral squamous cell carcinoma].
Wang XH; Zhang YY; Chen XM; Sun ZJ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Jan; 46(1):42-6. PubMed ID: 21418946
[TBL] [Abstract][Full Text] [Related]
10. Lip cancer and pre-cancerous lesions harbor TP53 mutations, exhibit allelic loss at 9p, 9q, and 17p, but no BRAFV600E mutations.
Correa GT; Bernardes VF; de Sousa SF; Diniz MG; Salles JM; Souza RP; De-Paula AM; Gomez RS; Gomes CC
Tumour Biol; 2015 Nov; 36(11):9059-66. PubMed ID: 26084614
[TBL] [Abstract][Full Text] [Related]
11. 17p13 (p53 locus), 5q21 (APC locus) and 9p21 (p16 locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non-small-cell lung cancer.
Sanz-Ortega J; Roig F; Al-Mousa MM; Saez MC; Muñoz A; Sanz-Esponera J; Callol L
Histol Histopathol; 2007 May; 22(5):541-5. PubMed ID: 17330809
[TBL] [Abstract][Full Text] [Related]
12. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
[TBL] [Abstract][Full Text] [Related]
13. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer.
Tsuji N; Furuse K; Asanuma K; Furuya M; Kondoh K; Kamagata C; Sasaki M; Kobayashi D; Yagihashi A; Takahashi H; Watanabe N
Breast Cancer Res Treat; 2004 Sep; 87(1):23-31. PubMed ID: 15377848
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
[TBL] [Abstract][Full Text] [Related]
17. Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women.
Querzoli P; Albonico G; di Iasio MG; Ferretti S; Rinaldi R; Cariello A; Pedriali M; Matteuzzi M; Maestri I; Nenci I
Breast Cancer Res Treat; 2001 Mar; 66(2):135-42. PubMed ID: 11437099
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features.
Otis CN; Krebs PA; Albuquerque A; Quezado MM; San Juan X; Sobel ME; Merino MJ
Int J Surg Pathol; 2002 Oct; 10(4):237-45. PubMed ID: 12490973
[TBL] [Abstract][Full Text] [Related]
19. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.
Nagahata T; Hirano A; Utada Y; Tsuchiya S; Takahashi K; Tada T; Makita M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
Breast Cancer; 2002; 9(3):208-15. PubMed ID: 12185331
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy.
Watatani M; Nagayama K; Imanishi Y; Kurooka K; Wada T; Inui H; Hirai K; Ozaki M; Yasutomi M
Breast Cancer Res Treat; 1993 Dec; 28(3):231-9. PubMed ID: 7912561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]